FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2159763673> ?p ?o ?g. }

• W2159763673 endingPage "142" @default.
• W2159763673 startingPage "133" @default.
• W2159763673 abstract "Vaccination against tumors relies on tumor-associated antigens, and has been quite successful with synthetic peptides used as immunogens. Gp100 is a human melanoma-associated antigen (hgp100) with a highly homologous mouse counterpart, pmel17/gp100 (mgp100), that is expressed in melanocytes and highly tumorigenic B16 melanoma cells. Since mgp100 is poorly immunogenic in mice, we used a xenoimmunization approach and vaccinated with the hgp100 immunogene. To that end, plasmid DNA encoding hgp100 was applied as a vaccine in combination with three synthetic peptides corresponding to putative cytotoxic T cell epitopes of hgp100. Immunization with DNA and peptide-pulsed spleen cells had a synergistic effect and provided significant protection against a challenge with poorly immunogenic B16-F0 malignant melanoma cells in the syngeneic C57BL/6 mouse model. Vaccination with either plasmid DNA or peptides alone delayed the onset of tumor formation, and reduced tumor growth 2-fold and 30-fold, respectively. However, while all animals vaccinated with DNA encoding hgp100 or with peptides eventually developed tumors, 30% of the animals treated with both vaccines remained tumor free and survived for the entire observation period of 150 days. Depletion of T cell subsets revealed that the protective effect observed after vaccination with plasmid DNA was mediated by CD4+ and CD8+ T cells, while protection following vaccination with DNA encoding hgp100 in combination with peptides appears to depend on CD4+ T cells only. Furthermore, we could also demonstrate a therapeutic effect of the combined DNA/peptide regime. A single treatment cycle consisting of injections of plasmid DNA and peptide-pulsed spleen cells led to a fourfold reduction in the growth rate of preexisting tumors. The data presented demonstrate that immunization with xenoantigens induces cross-species priming leading to an immunological response against the tumor-specific antigens." @default.
• W2159763673 created "2016-06-24" @default.
• W2159763673 creator A5021072263 @default.
• W2159763673 creator A5049872530 @default.
• W2159763673 creator A5087918957 @default.
• W2159763673 date "2001-02-21" @default.
• W2159763673 modified "2023-10-12" @default.
• W2159763673 title "Synergistic effect of a combined DNA and peptide vaccine against gp100 in a malignant melanoma mouse model" @default.
• W2159763673 cites W1494409817 @default.
• W2159763673 cites W1562228673 @default.
• W2159763673 cites W1600662889 @default.
• W2159763673 cites W1612135387 @default.
• W2159763673 cites W1638037042 @default.
• W2159763673 cites W1898024522 @default.
• W2159763673 cites W1973591436 @default.
• W2159763673 cites W1986340947 @default.
• W2159763673 cites W1990198913 @default.
• W2159763673 cites W1993228726 @default.
• W2159763673 cites W2008954472 @default.
• W2159763673 cites W2028289229 @default.
• W2159763673 cites W2054965969 @default.
• W2159763673 cites W2066964346 @default.
• W2159763673 cites W2076093278 @default.
• W2159763673 cites W2082341714 @default.
• W2159763673 cites W2085036470 @default.
• W2159763673 cites W2089051402 @default.
• W2159763673 cites W2115454016 @default.
• W2159763673 cites W2116293732 @default.
• W2159763673 cites W2119553086 @default.
• W2159763673 cites W2124800491 @default.
• W2159763673 cites W2142627742 @default.
• W2159763673 cites W2166630161 @default.
• W2159763673 cites W2169957856 @default.
• W2159763673 cites W2320270056 @default.
• W2159763673 cites W48916174 @default.
• W2159763673 cites W59350881 @default.
• W2159763673 doi "https://doi.org/10.1007/s001090000159" @default.
• W2159763673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11357937" @default.
• W2159763673 hasPublicationYear "2001" @default.
• W2159763673 type Work @default.
• W2159763673 sameAs 2159763673 @default.
• W2159763673 citedByCount "20" @default.
• W2159763673 countsByYear W21597636732014 @default.
• W2159763673 crossrefType "journal-article" @default.
• W2159763673 hasAuthorship W2159763673A5021072263 @default.
• W2159763673 hasAuthorship W2159763673A5049872530 @default.
• W2159763673 hasAuthorship W2159763673A5087918957 @default.
• W2159763673 hasBestOaLocation W21597636731 @default.
• W2159763673 hasConcept C147483822 @default.
• W2159763673 hasConcept C153911025 @default.
• W2159763673 hasConcept C154317977 @default.
• W2159763673 hasConcept C159047783 @default.
• W2159763673 hasConcept C167508917 @default.
• W2159763673 hasConcept C167672396 @default.
• W2159763673 hasConcept C195616568 @default.
• W2159763673 hasConcept C202751555 @default.
• W2159763673 hasConcept C203014093 @default.
• W2159763673 hasConcept C22070199 @default.
• W2159763673 hasConcept C22744801 @default.
• W2159763673 hasConcept C2776090121 @default.
• W2159763673 hasConcept C2777658100 @default.
• W2159763673 hasConcept C2780801004 @default.
• W2159763673 hasConcept C2780931953 @default.
• W2159763673 hasConcept C502942594 @default.
• W2159763673 hasConcept C54355233 @default.
• W2159763673 hasConcept C552990157 @default.
• W2159763673 hasConcept C86803240 @default.
• W2159763673 hasConcept C8891405 @default.
• W2159763673 hasConceptScore W2159763673C147483822 @default.
• W2159763673 hasConceptScore W2159763673C153911025 @default.
• W2159763673 hasConceptScore W2159763673C154317977 @default.
• W2159763673 hasConceptScore W2159763673C159047783 @default.
• W2159763673 hasConceptScore W2159763673C167508917 @default.
• W2159763673 hasConceptScore W2159763673C167672396 @default.
• W2159763673 hasConceptScore W2159763673C195616568 @default.
• W2159763673 hasConceptScore W2159763673C202751555 @default.
• W2159763673 hasConceptScore W2159763673C203014093 @default.
• W2159763673 hasConceptScore W2159763673C22070199 @default.
• W2159763673 hasConceptScore W2159763673C22744801 @default.
• W2159763673 hasConceptScore W2159763673C2776090121 @default.
• W2159763673 hasConceptScore W2159763673C2777658100 @default.
• W2159763673 hasConceptScore W2159763673C2780801004 @default.
• W2159763673 hasConceptScore W2159763673C2780931953 @default.
• W2159763673 hasConceptScore W2159763673C502942594 @default.
• W2159763673 hasConceptScore W2159763673C54355233 @default.
• W2159763673 hasConceptScore W2159763673C552990157 @default.
• W2159763673 hasConceptScore W2159763673C86803240 @default.
• W2159763673 hasConceptScore W2159763673C8891405 @default.
• W2159763673 hasIssue "2-3" @default.
• W2159763673 hasLocation W21597636731 @default.
• W2159763673 hasLocation W21597636732 @default.
• W2159763673 hasOpenAccess W2159763673 @default.
• W2159763673 hasPrimaryLocation W21597636731 @default.
• W2159763673 hasRelatedWork W1979044599 @default.
• W2159763673 hasRelatedWork W2009867644 @default.
• W2159763673 hasRelatedWork W2021824670 @default.
• W2159763673 hasRelatedWork W2060253881 @default.
• W2159763673 hasRelatedWork W2075879923 @default.

• next